Forty-six percent of U.S. adults have hypertension

Early detection of prediabetes may reduce risk for developing cardiovascular disease

Glycemic control not better in 2010 to 2018, despite more use of insulin pumps, continuous monitoring

Currently, there is no effective generic alternative to brand-name insulin

Revised risk score also improves newborn screening versus HLA genotyping alone

Recommendations suggest doctors prescribe individualized exercise training for these patients

No significant difference seen in frequency of live births, rates of ongoing, clinical, multiple pregnancy

Insulin spending rose from about $2,900 in 2012 to about $5,700 in 2016

Fracture risk up with T2DM and current use of rosiglitazone, pioglitazone regardless of glycemic control

Clinically significant and sustained reduction in glycated hemoglobin was observed with TTP399